Everhart Financial Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.54M | Buy |
19,053
+676
| +4% | +$125K | 0.41% | 36 |
|
|
2025
Q1 | $3.85M | Buy |
18,377
+1,097
| +6% | +$230K | 0.53% | 32 |
|
|
2024
Q4 | $3.07M | Buy |
17,280
+4,295
| +33% | +$763K | 0.63% | 33 |
|
|
2024
Q3 | $2.56M | Buy |
12,985
+1,299
| +11% | +$257K | 0.57% | 33 |
|
|
2024
Q2 | $2M | Buy |
11,686
+990
| +9% | +$170K | 0.52% | 34 |
|
|
2024
Q1 | $1.95M | Buy |
10,696
+4,059
| +61% | +$739K | 0.57% | 35 |
|
|
2023
Q4 | $1.03M | Sell |
6,637
-579
| -8% | -$89.7K | 0.36% | 56 |
|
|
2023
Q3 | $1.08M | Buy |
7,216
+1,064
| +17% | +$159K | 0.46% | 48 |
|
|
2023
Q2 | $829K | Sell |
6,152
-836
| -12% | -$113K | 0.34% | 62 |
|
|
2023
Q1 | $1.11M | Buy |
6,988
+442
| +7% | +$70.4K | 0.5% | 41 |
|
|
2022
Q4 | $1.06M | Buy |
6,546
+535
| +9% | +$86.5K | 0.53% | 40 |
|
|
2022
Q3 | $806K | Buy |
6,011
+438
| +8% | +$58.7K | 0.45% | 41 |
|
|
2022
Q2 | $853K | Buy |
5,573
+1,288
| +30% | +$197K | 0.52% | 39 |
|
|
2022
Q1 | $694K | Buy |
4,285
+1,484
| +53% | +$240K | 0.4% | 50 |
|
|
2021
Q4 | $379K | Buy |
+2,801
| New | +$379K | 0.23% | 82 |
|
|
2021
Q3 | – | Sell |
-2,473
| Closed | -$278K | – | 102 |
|
|
2021
Q2 | $278K | Buy |
+2,473
| New | +$278K | 0.19% | 78 |
|